Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Part of paid clinical trials in Avondale, Arizona.
- Sponsor
- Novartis Pharmaceuticals
- Study ID
- NCT06331312
- Phase
- PHASE3
- Status
- Active Not Recruiting
Conditions
- Polymyalgia Rheumatica
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- Secukinumab — BIOLOGICAL2 x 150mg/1mL PFS secukinumab
Study Details
The purpose of this extension study is to assess the safety and tolerability of secukinumab when administered long-term in patients with polymyalgia rheumatica.
Key Dates
- Start date
- Jun 28, 2024
- Status verified
- Jun 2026
- Primary completion
- May 8, 2028
- Completion
- May 8, 2028
Study Design
- Enrollment
- 161 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Secukinumab 300mgAll eligible participants will receive secukinumab 300 mg s.c. (2 x 150mg/1mL PFS secukinumab) from baseline and every 4 weeks up to 2 years. The study medication may be modified/adjusted after the initial doses of 300mg s.c. (decreased to 150mg s.c. q4w or increased again from 150mg s.c. q4w to 300mg s.c. q4w) if deemed appropriate by the investigator. Dose modification/adjustment may only occur from Week 24 visit onwards. The modification/adjustment of the study medication will be determined at a site visit.
Primary Outcome Measure
Incidences of treatment emergent adverse events (AEs) and serious adverse events (SAEs) [ Time Frame: After the first dose of study treatment and within 84 days after the last dose ]
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Arizona Arthritis and Rheumatology Associates PLLC | Avondale | Arizona | 85392 | - |
| Sun Valley Arthritis Center Ltd | Peoria | Arizona | 85381 | - |
| Center for Rheumatology Research | West Hills | California | 91307 | - |
| Millennium Clinical Trials | Westlake Village | California | 91361 | - |
| Rheumatology Associates of South Florida | Boca Raton | Florida | 33486 | - |
| West Broward Rheumatology Associates Inc | Tamarac | Florida | 33321 | - |
| Klein and Associates | Hagerstown | Maryland | 21740 | - |
| Clinical Research Inst of MI | Saint Clair Shores | Michigan | 48081 | - |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | - |
| Paramount Med Rsrch and Consult LLC | Middleburg Heights | Ohio | 44130 | - |
| Accurate Clinical Research Inc | Houston | Texas | 77089 | - |
| Prolato Clinical Research Center | Houston | Texas | 77054 | - |
| Advanced Rheumatology of Houston | Spring | Texas | 77382 | - |
Find similar trials in Avondale, AZ
By research site
Arizona Arthritis and Rheumatology Associates PLLC· Avondale, AZSun Valley Arthritis Center Ltd· Peoria, AZCenter for Rheumatology Research· West Hills, CAMillennium Clinical Trials· Westlake Village, CARheumatology Associates of South Florida· Boca Raton, FLWest Broward Rheumatology Associates Inc· Tamarac, FL
Related Studies
- A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor ImmunotherapyRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Sarilumab Efficacy and Safety in Adults With Early Polymyalgia RheumaticaPHASE4 · Recruiting · Sanofi · Denver, Colorado
- Rheumatology Patient Registry and BiorepositoryRecruiting · Yale University · New Haven, Connecticut